Unique Hand-Over-Hand Rotation Transports Molecules
Through Cells
(Philadelphia,
PA) - Within every neuron is a vast protein trail system
traversed by a small protein engine called Myosin V.
The long-standing question of how this molecule moves
may have finally been resolved by researchers from the
University of Pennsylvania School of Medicine.
Their findings, presented in this week's issue of Nature,
show how myosin V can move 'hand-over-hand' on tracks,
composed of a protein called actin, without completely
letting go at any point. According to the researchers,
myosin V offers a fascinating example of how cells convert
chemical energy into motion, and may offer a natural
example of molecular motors for the purposes of nanotechnology.
"There are a number of theories on how
this molecule moves. What concerned me was how this
little myosin motor can move along the track without
letting go and floating off into the cytoplasm of the
cell," said Yale E. Goldman, MD, PhD, professor
in Penn's Department of Physiology and director of the
Pennsylvania Muscle Institute (PMI). "It turns out that
myosin tilts as it steps along the actin track - one
head attaches to the track and then the molecule rotates
allowing the other head to attach - much like a child
on a playground crosses the monkey-bars hand-over-hand."
Myosin V, which is also found in pigment
cells, is a protein that consists of two heads attached
to a long tail, which can bind to the motor's molecular
'cargo.' Myosin travels over long filaments of a protein
called actin. This cytoskeletal network is a feature
of all multicellular creatures, and it is used to transport
molecules throughout a single cell. In humans, Griscelli
disease, which is characterized by neurological deficits
and a lack of pigment, stems from non-functioning myosin
V.
Goldman and his colleagues were able to
study the hand-over-hand motion of a single myosin motor
in action thanks to an innovative microscopic technique
created by Joseph N. Forkey, PhD, a post-doctoral
researcher at Goldman's PMI laboratory. The technique,
called single-molecule fluorescence polarization, involved
labeling myosin V with a fluorescent tag. The researchers
then used a laser beam to hit the tag, creating an electromagnetic
field that could resolve the angle at which the molecule
tilts.
"Using single-molecule fluorescence polarization,
we could detect the three-dimensional orientation of
myosin V tilting back and forth between two well-defined
angles as it teetered along," said Goldman.
Researchers contributing to this work
include Margot E. Quinlan and M. Alexander Shaw of PMI
and John E. T. Corrie of the National Institute for
Medical Research in London, UK.
This research was supported by grants
from the National Institutes of Health and the Medical
Research Council.
# # #
Editor's Note: Click here
for an illustration of myosinV in motion.
.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.